Hewlett-Packard ties in Aspect's technology:
This article was originally published in Clinica
Executive Summary
Hewlett-Packard is to integrate Aspect Medical Systems' Bispectral Index (BIS) technology into its Viridia 24/265 and Viridia CMS patient monitors under a worldwide licensing agreement. Non-invasive BIS monitoring provides a direct measurement of the effects of anaesthesia on the brain, via a sensor placed on the forehead to capture EEG signals. Under the agreement, HP will assist in the distribution of Aspect's stand-alone A-2000 BIS monitor and BIS sensors outside the US. Separately, HP has announced that its test and measurement company, which is being spun-off from the computer and printer business, will be called Agilent Technologies.
You may also be interested in...
Purespring Therapeutics: Pioneering Gene Therapy For Kidney Disorders
Interview: recently appointed CEO Richard Francis will apply his background in big pharma and biotech to building the UK start-up Purespring Therapeutics with a focus on using gene therapy technology to target renal diseases.
Sandoz Pioneers Posaconazole And Silodosin In Canada
Sandoz Canada has become the first manufacturer to launch generic versions of posaconazole and silodosin in Canada. The company launched the generic version of Allergan’s Rapaflo (silodosin) after a Canadian court ruled that Sandoz did not infringe a key formulation patent.
Amarin Pulls Insurer Into Hikma/Vascepa Induced Infringement Suit
US healthcare insurance provider Health Net failed to respect Amarin’s patent rights in the way it distributed Hikma’s generic version of Vascepa (icosapent ethyl), the originator contends in an expanded induced infringement suit.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: